Renoprotective effect of a combination of garlic and telmisartan against ischemia/reperfusion-induced kidney injury in obese rats

References

• Hafner S, Hillenbrand A, Knippschild U, Radermacher P. The obesity paradox and acute kidney injury: beneficial effects of hyper-inflammation? Crit Care 2013;17:1023.
   PubMed Web of Science ®Google Scholar
• Othman M, Kawar B, El Nahas AM. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study. Nephron Clin Pract 2009;113:c16–c23.
   Google Scholar
• Kelz RR, Reinke CE, Zubizarreta JR, Wang M, Saynisch P, Even-Shoshan O. et al. Acute kidney injury, renal function, and the elderly obese surgical patient: a matched case-control study. Ann Surg 2013;258:359–363.
   PubMed Web of Science ®Google Scholar
• Lafrance JP, Miller DR. Acute kidney injury associates with increased long-term mortality. Am J Soc Nephrol JASN 2010;21:345–352.
   PubMed Web of Science ®Google Scholar
• Ploeg RJ, van Bockel JH, Langendijk PT, Groenewegen M, van der Woude FJ, Persijn GG, et al. Effect of preservation solution on results of cadaveric kidney transplantation. The European Multicentre Study Group. Lancet 1992;340:129–137.
   PubMed Web of Science ®Google Scholar
• Jongbloed F, de Bruin RW, Pennings JL, Payán-Gómez C, van den Engel S, van Oostrom CT, et al. Preoperative fasting protects against renal ischemia-reperfusion injury in aged and overweight mice. PLoS One 2014;9:e100853.
   Google Scholar
• Korkmaz A, Kolankaya D. The protective effects of ascorbic acid against renal ischemia-reperfusion injury in male rats. Ren Fail 2009;31:36–43.
   PubMed Web of Science ®Google Scholar
• Agarwal KC. Therapeutic actions of garlic constituents. Med Res Rev 1996;16:111–124.
   PubMed Web of Science ®Google Scholar
• Augusti KT. Therapeutic values of onion (Allium cepa L.) and garlic (Allium sativum L.). Indian Exp J Biol 1996;34:634–640.
   PubMedGoogle Scholar
• Kyo E, Suzuki A, Kakimoto M, Ushijima M, Kasuga S, Itakura Y. Immunomodulation and antitumor activities of aged garlic extract. Phytomedicine 1998;5:259–267.
   PubMed Web of Science ®Google Scholar
• Moriguchi T, Takashina K, Chu PJ, Saito H, Nishiyama N. Prolongation of life span and improved learning in the senescence accelerated mouse produced by aged garlic extract. Biol Pharm Bull 1994;17:1589–1594.
   PubMed Web of Science ®Google Scholar
• Lawson LD. Garlic: a review of its medicinal effects and indicated active compounds. In: Lawson LD, Bauer R, eds. Phytomedicines of Europe: chemistry and biological activity. Washington DC: American Chemical Society; 1998: 176–209.
   Google Scholar
• Chung LY. The antioxidant properties of garlic compounds: allyl cysteine, alliin, allicin, and allyl disulfide. Med J Food 2006;9:205–213.
   PubMed Web of Science ®Google Scholar
• Savas M, Yeni E, Ciftci H, Yildiz F, Gulum M, Keser BS, et al. The antioxidant role of oral administration of garlic oil on renal ischemia-reperfusion injury. Ren Fail 2010;32:362–367.
   PubMed Web of Science ®Google Scholar
• Bagheri F, Gol A, Dabiri S, Javadi A. Preventive effect of garlic juice on renal reperfusion injury. Iran J Kidney Dis 2011;5:194–200.
   PubMed Web of Science ®Google Scholar
• Seujange Y, Eiam-Ong S, Tirawatnapong T, Eiam-Ong S. Role of angiotensin II on dihydrofolate reductase, GTP-cyclohydrolase 1 and nitric oxide synthase expressions in renal ischemia-reperfusion. Am Nephrol J 2008;28:692–700.
   PubMed Web of Science ®Google Scholar
• Makino H, Haneda M, Babazono T, Moriya T, Ito S, Iwamoto Y, et al. The telmisartan renoprotective study from incipient nephropathy to overt nephropathy – rationale, study design, treatment plan and baseline characteristics of the incipient to overt: angiotensin II receptor blocker, telmisartan, investigation on type 2 diabetic nephropathy (INNOVATION) study. Int J Med Res 2005;33:677–686.
   PubMed Web of Science ®Google Scholar
• Barnett A. Preventing renal complications in type 2 diabetes: results of the diabetics exposed to telmisartan and enalapril trial. Am J Soc Nephrol 2006;17:S132–S135.
   PubMed Web of Science ®Google Scholar
• Aranda P, Segura J, Ruilope LM, Aranda FJ, Frutos MA, Lopez V, de Novales E. Long-term renoprotective effects of standard versus high doses of telmisartan in hypertensive nondiabetic nephropathies. Am Kidney J Dis 2005;46:1074–1079.
   PubMed Web of Science ®Google Scholar
• Wienen W, Richard S, Champeroux P, Audeval-Gerard C. Comparative antihypertensive and renoprotective effects of telmisartan and lisinopril after long-term treatment in hypertensive diabetic rats. Renin J Angiotensin Aldosterone Syst 2001;2:31–36.
   PubMed Web of Science ®Google Scholar
• Mandarim-de-Lacerda CA, Pereira LM. Effects of telmisartan on preexistent cardiac and renal lesions in spontaneously hypertensive mature rats. Histol Histopathol 2004;19:727–733.
   PubMed Web of Science ®Google Scholar
• Tsunenari I, Ohmura T, Seidler R, Chachin M, Hayashi T, Konomi A, et al. Renoprotective effects of telmisartan in the 5/6 nephrectomised rats. J Renin Angiotensin Aldosterone Syst 2007;8:93–100.
   PubMed Web of Science ®Google Scholar
• Benson SC, Pershadsingh HA, Ho CI, Chittiboyina A, Desai P, Pravenec M, et al. Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARγ-modulating activity. Hypertension 2004;43:993–1002.
   PubMed Web of Science ®Google Scholar
• Cianchetti S, Del Fiorentino A, Colognato R, Di Stefano R, Franzoni F, Pedrinelli R. Anti-inflammatory and anti-oxidant properties of telmisartan in cultured human umbilical vein endothelial cells. Atherosclerosis 2008;198:22–28.
   PubMed Web of Science ®Google Scholar
• Fouad AA, Qureshi HA, Al-Sultan AI, Yacoubi MT, Al-Melhim WN. Nephroprotective effect of telmisartan in rats with ischemia/reperfusion renal injury. Pharmacology 2010;85:158–167.
   PubMed Web of Science ®Google Scholar
• Tawfik MK. Renoprotective activity of telmisartan versus pioglitazone on ischemia/reperfusion induced renal damage in diabetic rats. Eur Rev Med Pharmacol Sci 2012;16:600–609.
   PubMed Web of Science ®Google Scholar
• Kocak C, Kocak FE, Akcilar R, Bayat Z, Aras B, Metineren MH, et al. Effects of captopril, telmisartan and bardoxolone methyl (CDDO-Me) in ischemia-reperfusion-induced acute kidney injury in rats: an experimental comparative study. Clin Exp Pharmacol Physiol 2016;43:230–241.
   PubMed Web of Science ®Google Scholar
• Harirforoosh S, Aghazadeh‐Habashi A, Jamali F. Extent of renal effect of cyclo‐oxygenase‐2‐selective inhibitors is pharmacokinetic dependent. Clin Exp Pharmacol Physiol 2006;33:917–924.
   PubMed Web of Science ®Google Scholar
• Shiju TM, Rajesh NG, Viswanathan P. Renoprotective effect of aged garlic extract in streptozotocin-induced diabetic rats. Indian J Pharmacol 2013;45:18–23.
   PubMed Web of Science ®Google Scholar
• Al-Qattan K, Thomson M, Ali M, Mansour M, Divya J. Garlic attenuate hypertension and renal clearance in streptozotocin-diabetic rats: a possible role of plasma and kidney angiotensin converting enzyme 1. FASEB J 2014;28:689.
   Google Scholar
• Omotoso GO, Saibu SA, Akinlolu A, Kadir E. Effects of aqueous extract of garlic and vitamin C on the kidney of albino rats. Asian Exp J Biol Sci 2011;2:455–461.
   Google Scholar
• Huang JH, Huang XH, Chen ZY, Zheng QS, Sun RY. Dose conversion among different animals and healthy volunteers in pharmacological study. Chin J Clin Pharmacol Ther 2004;9:1069–1072.
   Google Scholar
• Zhang Q, Xiao X, Li M, Li W, Yu M, Zhang H, et al. Telmisartan improves kidney function through inhibition of the oxidative phosphorylation pathway in diabetic rats. Mol J Endocrinol 2012;49:35–46.
   PubMed Web of Science ®Google Scholar
• Williams P, Lopez H, Britt D, Chan C, Ezrin A, Hottendorf R. Characterization of renal ischemia-reperfusion injury in rats. J Pharmacol Toxicol Methods 1997;37:1–7.
   PubMed Web of Science ®Google Scholar
• Youssef MI, Mahmoud AA, Abdelghany RH. A new combination of sitagliptin and furosemide protects against remote myocardial injury induced by renal ischemia/reperfusion in rats. Biochem Pharmacol 2015;96:20–29.
   PubMed Web of Science ®Google Scholar
• Neto JS, Nakao A, Kimizuka K, Romanosky AJ, Stolz DB, Uchiyama T, et al. Protection of transplant-induced renal ischemia-reperfusion injury with carbon monoxide. Am Physiol J Renal Physiol 2004;287:F979–F989.
   PubMed Web of Science ®Google Scholar
• Alzoubi KH, Abdul-Razzak KK, Khabour OF, Al-Tuweiq GM, Alzubi MA, Alkadhi KA. Adverse effect of combination of chronic psychosocial stress and high fat diet on hippocampus-dependent memory in rats. Behav Brain Res 2009;204:117–123.
   PubMed Web of Science ®Google Scholar
• Mohamed HE, El-Swefy SE, Rashed LA, Abd El-Latif SK. Biochemical effect of a ketogenic diet on the brains of obese adult rats. Clin J Neurosci 2010;17:899–904.
   PubMed Web of Science ®Google Scholar
• Goyal A, Goyal R, Sharma PL, Malik ZA. Beneficial effect of combination of metformin and telmisartan on high fat diet-induced obesity in Wistar rats. Asian J Pharm Clin Res 2011;4:106–111.
   Google Scholar
• Oh J, Rabb H. Adiponectin: an enlarging role in acute kidney injury. Kidney Int 2013;83:546–548.
   PubMed Web of Science ®Google Scholar
• Wahba IM, Mak RH. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease. Clin Am J Soc Nephrol 2007;2:550–562.
   PubMed Web of Science ®Google Scholar
• Fantuzzi G. Adiponectin and inflammation: consensus and controversy. Allergy J Clin Immunol 2008;121:326–330.
   PubMed Web of Science ®Google Scholar
• Kappes A, Loffler G. Influences of ionomycin, dibutyryl-cycloAMP and tumour necrosis factor-alpha on intracellular amount and secretion of apM1 in differentiating primary human preadipocytes. Horm Metab Res 2000;32:548–554.
   PubMed Web of Science ®Google Scholar
• Li L, Yang G, Shi S, Yang M, Liu H, Boden G. The adipose triglyceride lipase, adiponectin and visfatin are downregulated by tumor necrosis factor-alpha (TNF-alpha) in vivo. Cytokine 2009;45:12–19.
   PubMed Web of Science ®Google Scholar
• van Stijn CMW, Kim J, Barish GD, Tietge UJF, Tangirala RK. Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis. PLoS one 2014;9:e86404.
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772–783.
   PubMed Web of Science ®Google Scholar
• Toussirot E, Binda D, Gueugnon C, Dumoulin G. Adiponectin in autoimmune diseases. Curr Med Chem 2012;19:5474–5480.
   PubMed Web of Science ®Google Scholar
• Perri A, Vizza D, Lupinacci S, Toteda G, De Amicis F, Leone F, et al. Adiponectin secreted by tubular renal cells during LPS exposure worsens the cellular inflammatory damage. Nephrol J 2016;29:185–194.
   PubMed Web of Science ®Google Scholar
• Pan QR, Ren YL, Zhu JJ, Hu YJ, Zheng JS, Fan H, Xu Y, Wang G, Liu WX. Resveratrol increases nephrin and podocin expression and alleviates renal damage in rats fed a high-fat diet. Nutrients 2014;6:2619–2631.
   PubMed Web of Science ®Google Scholar
• Gao G, Zhang B, Ramesh G, Betterly D, Tadagavadi RK, Wang W, Reeves WB. TNF-α mediates increased susceptibility to ischemic AKI in diabetes. Am Physiol J Renal Physiol 2013;304:F515–F521.
   PubMed Web of Science ®Google Scholar
• Wu Y, Liu Z, Xiang Z, Zeng C, Chen Z, Ma X, Li L. Obesity-related glomerulopathy: insights from gene expression profiles of the glomeruli derived from renal biopsy samples. Endocrinology 2006;147:44–50.
   PubMed Web of Science ®Google Scholar
• Chow FY, Nikolic-Paterson DJ, Ma FY, Ozols E, Rollins BJ, Tesch GH. Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db. Diabetologia 2007;50:471–480.
   PubMed Web of Science ®Google Scholar
• Olusi SO. Obesity is an independent risk factor for plasma lipid peroxidation and depletion of erythrocyte cytoprotectic enzymes in humans. Int Obes J Relat Metab Disord 2002;26:1159.
   PubMed Web of Science ®Google Scholar
• Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int Obes J (Lond) 2006;30:400–418.
   PubMed Web of Science ®Google Scholar
• Lachieitner M, Koch T, Harold M, Dzien A, Hoppiahler F. Tumour necrosis factor-alpha plasma level in patients with type 1 diabetes mellitus and its association with glycaemic control and cardiovascular risk factors. Intern J Med 2000;248:67–76.
   PubMed Web of Science ®Google Scholar
• Noeman SA, Hamooda HE, Baalash AA. Biochemical study of oxidative stress markers in the liver, kidney and heart of high fat diet induced obesity in rats. Diabetol Metab Syndr 2011;3:17.
   PubMed Web of Science ®Google Scholar
• Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. Clin J Invest 2003;112:1821–1830.
   PubMed Web of Science ®Google Scholar
• Lumeng CN, Bodzin JL, Saltiel AR. Obesity induces a phenotypic switch in adipose tissue macrophage polarization. Clin J Invest 2007;117:175–184.
   PubMed Web of Science ®Google Scholar
• Ohashi K, Parker JL, Ouchi N, Higuchi A, Vita JA, Gokce N, et al. Adiponectin promotes macrophage polarization toward an anti-inflammatory phenotype. Biol J Chem 2010;285:6153–6160.
   Web of Science ®Google Scholar
• Gordon S. The macrophage: past, present and future. Eur Immunol J 2007;37:S9–S17.
   PubMed Web of Science ®Google Scholar
• Fujisaka S, Usui I, Bukhari A, Ikutani M, Oya T, Kanatani Y, et al. Regulatory mechanisms for adipose tissue M1 and M2 macrophages in diet-induced obese mice. Diabetes 2009;58:2574–2582.
   PubMed Web of Science ®Google Scholar
• Linden MA, Pincu Y, Martin SA, Woods JA, Baynard T. Moderate exercise training provides modest protection against adipose tissue inflammatory gene expression in response to high-fat feeding. Physiol Rep 2014;2:e12071.
   Google Scholar
• Zeyda M, Farmer D, Todoric J, Aszmann O, Speiser M, Gyori G, et al. Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int Obes J (Lond) 2007;31:1420–1428.
   PubMed Web of Science ®Google Scholar
• Shaul ME, Bennett G, Strissel KJ, Greenberg AS, Obin MS, Dynamic. M2-like remodeling phenotypes of CD11c + adipose tissue macrophages during high-fat diet–induced obesity in mice. Diabetes 2010;59:1171–1181.
   PubMed Web of Science ®Google Scholar
• Kellum JA, Levin N, Bouman C, Lameire N. Developing a consensus classification system for acute renal failure. Curr Opin Crit Care 2002;8:509–514.
   PubMedGoogle Scholar
• Kelly KJ. Distant effects of experimental renal ischemia/reperfusion injury. Am J Soc Nephrol 2003;14:1549–1558.
   PubMed Web of Science ®Google Scholar
• Chen YT, Tsai TH, Yang CC, Sun CK, Chang LT, Chen HH, et al. Yip HExendin K-4 and sitagliptin protect kidney from ischemia-reperfusion injury through suppressing oxidative stress and inflammatory reaction. Translational J Med 2013;11:270.
   PubMed Web of Science ®Google Scholar
• Burne-Taney MJ, Kofler J, Yokota N, Weisfeldt M, Traystman RJ, Rabb H. Acute renal failure after whole body ischemia is characterized by inflammation and T cell-mediated injury. Am Physiol J Renal Physiol 2003;285:F87–F94.
   PubMed Web of Science ®Google Scholar
• Karin M, Ben-Neriah Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 2000;18:621–663.
   PubMed Web of Science ®Google Scholar
• Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelial-dependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 2007;101:234–247.
   PubMed Web of Science ®Google Scholar
• Bonventre JV, Zuk A. Ischemic acute renal failure: an inflammatory disease. Kidney Int 2004;66:480–485.
   PubMed Web of Science ®Google Scholar
• Feitoza CQ, Goncalves GM, Semedo P, Cenedeze MA, Pinheiro HS, Beraldo FC, et al. Inhibition of COX 1 and 2 prior to renal ischemia/reperfusion injury decreases the development of fibrosis. Mol Med 2008;14:724–730.
   PubMed Web of Science ®Google Scholar
• Nikolic-Paterson DJ, Atkins RC. The role of macrophages in glomerulonephritis. Nephrol. Dialysis Transplant 2001;16:3–7.
   PubMed Web of Science ®Google Scholar
• Eardley KS, Kubal C, Zehnder D, Quinkler M, Lepenies J, Savage CO, et al. The role of capillary density, macrophage infiltration and interstitial scarring in the pathogenesis of human chronic kidney disease. Kidney Int 2008;74:495–504.
   PubMed Web of Science ®Google Scholar
• Nikolic-Paterson DJ, Wang S, Lan HY. Macrophages promote renal fibrosis through direct and indirect mechanisms. Kidney Int Suppl 2014;4:34–38.
   Web of Science ®Google Scholar
• Yang N, Wu LL, Nikolic-Paterson DJ, Ng YY, Yang WC, Mu W, et al. Local macrophage and myofibroblast proliferation in progressive renal injury in the rat remnant kidney. Nephrol Dialysis Transplant 1998;13:1967–1974.
   PubMed Web of Science ®Google Scholar
• Noiri E, Nakao A, Uchida K, Tsukahara H, Ohno M, Fujita T, et al. Oxidative and nitrosative stress in acute renal ischemia. Am Physiol J Renal Physiol 2001;281:F948–F957.
   PubMed Web of Science ®Google Scholar
• Canacankatan N, Sucu N, Aytacoglu B, Gul OE, Gorur A, Korkmaz B, et al. Affirmative effects of iloprost on apoptosis during ischemia-reperfusion injury in kidney as a distant organ. Ren Fail 2012;34:111–118.
   PubMed Web of Science ®Google Scholar
• Cai H, Griendling KK, Harrison DG. The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 2003;24:471–478.
   PubMed Web of Science ®Google Scholar
• Bhalodia Y, Sheth N, Vaghasiya J, Jivani N. Role of fenofibrate alone and in combination with telmisartan on renal ischemia/reperfusion injury. Renal Fail 2010;32:1088–1094.
   PubMed Web of Science ®Google Scholar
• Volti GL, Sorrenti V, Murabito P, Galvano F, Veroux M, Gullo A, et al. Pharmacological induction of heme oxygenase-1 inhibits iNOS and oxidative stress in renal ischemia-reperfusion injury. Transplant Proc 2007;39:2986–2991.
   PubMed Web of Science ®Google Scholar
• Flamm ES, Demopoulos HB, Seligman ML, Poser RG, Ransohoff J. Free radicals in cerebral ischemia. Stroke; J Cereb Circ 1978;9:445–447.
   Google Scholar
• Guarnieri C, Flamigni F, Caldarera CM. Role of oxygen in the cellular damage induced by re-oxygenation of hypoxic heart. Mol J Cell Cardiol 1980;12:797–808.
   PubMed Web of Science ®Google Scholar
• Guven A, Uysal B, Akgul O, Cermik H, Gundogdu G, Surer I, et al. Scavenging of peroxynitrite reduces renal ischemia/reperfusion injury. Ren Fail 2008;30:747–754.
   PubMed Web of Science ®Google Scholar
• Honma S, Takahashi N, Shinohara M, Nakamura K, Mitazaki S, Abe S, et al. Amelioration of cisplatin-induced mouse renal lesions by a cyclooxygenase (COX)-2 selective inhibitor. Eur Pharmacol J 2013;715:181–188.
   PubMed Web of Science ®Google Scholar
• Segoviano-Murillo S, Sanchez-Gonzalez DJ, Martinez-Martinez CM, Cruz C, Maldonado PD, Pedraza-Chaverri J. S-allylcysteine ameliorates ischemia and reperfusion induced renal damage. Phytother Res 2008;22:836–840.
   PubMed Web of Science ®Google Scholar
• Pedraza-Chaverri J, Barrera D, Maldonado PD, Chirino YI, Macías-Ruvalcaba NA, Medina-Campos ON, et al. S-allylmercaptocysteine scavenges hydroxyl radical and singlet oxygen in vitro and attenuates gentamicin-induced oxidative and nitrosative stress and renal damage in vivo. BMC Clin Pharmacol 2004;4:5.
   PubMedGoogle Scholar
• Keophiphath M, Priem F, Jacquemond-Collet I, Clément K, Lacasa D. 1,2-vinyldithiin from garlic inhibits differentiation and inflammation of human preadipocytes. Nutr J 2009;139:2055–2060.
   Web of Science ®Google Scholar
• Munger MA. Use of Angiotensin receptor blockers in cardiovascular protection: current evidence and future directions. P T 2011;36:22–40.
   PubMedGoogle Scholar
• Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R, Rodriguez-Iturbe B. Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. Pharmacol J Exp Ther 2007;323:85–93.
   PubMed Web of Science ®Google Scholar
• Arab HH, Al-Shorbagy MY, Abdallah DM, Nassar NN. Telmisartan attenuates colon inflammation, oxidative perturbations and apoptosis in a rat model of experimental inflammatory bowel disease. PLoS One 2014;9:e97193. e97193.
   Google Scholar
• Fujisaka S, Usui I, Kanatani Y, Ikutani M, Takasaki I, Tsuneyama K, et al. Telmisartan improves insulin resistance and modulates adipose tissue macrophage polarization in high-fat-fed mice. Endocrinology 2011;152:1789–1799.
   PubMed Web of Science ®Google Scholar
• Inoue T, Taguchi I, Abe S, Toyoda S, Sakuma M, Node K. Inhibition of intestinal cholesterol absorption might explain cholesterol-lowering effect of telmisartan. Clin J Pharm Ther 2011;36:103–110.
   PubMed Web of Science ®Google Scholar
• Baden T, Yamawaki H, Saito K, Mukohda M, Okada M, Hara Y. Telmisartan inhibits methylglyoxal-mediated cell death in human vascular endothelium. Biochem Biophys Res Commun 2008;373:253–257.
   PubMed Web of Science ®Google Scholar
• Yao Y, Zou R, Liu X, Jiang J, Huang Q, He Y, et al. Telmisartan but not valsartan inhibits TGF-beta-mediated accumulation of extracellular matrix via activation of PPARgamma. Huazhong J Univ Sci Technol Med Sci 2008;28:543–548.
   Web of Science ®Google Scholar
• Nakamura T, Fujiwara N, Sato E, Ueda Y, Sugaya T, Koide H. Renoprotective effects of various angiotensin II receptor blockers in patients with early-stage diabetic nephropathy. Kidney Blood Press Res 2010;33:213–220.
   PubMed Web of Science ®Google Scholar
• Calistro Neto JP, Torres Rda C, Goncalves GM, Silva LM, Domingues MA, Módolo NS, et al. Parecoxib reduces renal injury in an ischemia/reperfusion model in rats. Acta Cir Bras 2015;30:270–276.
   PubMed Web of Science ®Google Scholar
• Musu M, Finco G, Antonucci R, Polati E, Sanna D, Evangelista M, Ribuffo D, Schweiger V, Fanos V. Acute nephrotoxicity of NSAID from the foetus to the adult. Eur Rev Med Pharmacol Sci 2011;15:1461–1472.
   PubMed Web of Science ®Google Scholar
• Schneider MP, Sullivan JC, Wach PF, Boesen EI, Yamamoto T, Fukai T, Harrison DG, Pollock DM, Pollock JS. Protective role of extracellular superoxide dismutase in renal ischemia/reperfusion injury. Kidney Int 2010;78:374–381.
   PubMed Web of Science ®Google Scholar
• Teplan V Jr, Vyhnánek F, Rürlich G, Haluzík M, Racek J, Vyhnankova I, et al. Increased proinflammatory cytokine production in adipose tissue of obese patients with chronic kidney disease. Wien Klin Wochenschr 2010;122:466–473.
   PubMed Web of Science ®Google Scholar
• Jin X, Chen J, Hu Z, Chan L, Wang Y. Genetic deficiency of adiponectin protects against acute kidney injury. Kidney Int 2013;83:604–614.
   PubMed Web of Science ®Google Scholar
• Cheng CF, Lian WS, Chen SH, Lai PF, Li HF, et al. Protective effects of adiponectin against renal ischemia-reperfusion injury via prostacyclin-PPARα-heme oxygenase-1 signaling pathway. Cell J Physiol 2012;227:239–249.
   PubMed Web of Science ®Google Scholar
• Mandal P, Pratt BT, Barnes M, McMullen MR, Nagy LE. Molecular mechanism for adiponectin-dependent M2 macrophage polarization: link between the metabolic and innate immune activity of full-length adiponectin. Biol J Chem 2011;286:13460–13469.
   Web of Science ®Google Scholar
• Mehta PK, Griendling KK. Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am Physiol J Cell Physiol 2007;292:C82–C97.
   PubMed Web of Science ®Google Scholar